PRECISIONBIOLOGICS
Menu
↗
PRECISION BIOLOGICS / LOCATIONS

Biologics Supplier for Dermatology and Medspas in Gainesville, FL

Precision Biologics supplies Wharton's jelly tissue products and extracellular vesicle products to licensed medspas operating under physician supervision, dermatology practices, and aesthetic or plastic surgery practices in Gainesville, Florida. Every account is tied to a verified NPI number for the ordering provider or medical director. Lot-level documentation, including certificates of analysis, is provided to qualified accounts before any order ships.

REGISTRY DATA / FL

Gainesville

NPPES registry listings, primary taxonomy, retrieved 2026-10-27

101
Dermatology
67
Plastic Surgery
34
Source: NPPES NPI Registry ↗

How aesthetic practices structure vendor approval

In a dermatology and aesthetic market the size of Gainesville, vendor approval for a new biologics line typically runs through the supervising physician or medical director rather than front-desk staff, since the decision touches both the practice's service menu and its compliance obligations.

That review generally covers the supplier's registration documentation, a sample certificate of analysis, a donor eligibility summary, and a written description of recovery, processing, and release testing.

NPI verification before ordering

Precision Biologics ties account access to a verified NPI number for the supervising physician or medical director of record, which fits how most dermatology and plastic surgery practices already document oversight of a medspa's service offerings. Multi-location practices can confirm provider NPI status through the public NPPES registry when setting up a new account.

Receiving shipments at an aesthetic practice

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers built to maintain a -80 degree C chain of custody, while lyophilized exosome products are shelf-stable and are handled per the instructions in the product insert.

Aesthetic practices and medspas should designate a specific receiving contact, since front-desk and treatment-room schedules can make it easy to miss a narrow delivery window compared with a surgical facility with dedicated receiving staff.

Florida licensure and scope-of-practice checks

Medical spa supervision arrangements in Florida vary by practice, so confirming the supervising physician's scope of practice with the relevant Florida licensing board and the practice's own counsel is a necessary step before adding any regenerative biologic to a service menu.

Florida's SB 1768, effective July 1, 2025, addresses physician use of certain non-FDA-approved stem cell therapies under informed consent rules but does not change federal FDA oversight of the product itself; practices should confirm its relevance, if any, with counsel rather than rely on it as a basis for marketing claims. Precision Biologics supplies documented products and records only and does not advise on clinical use.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.

FAQ

Frequently asked questions

Can a medspa in Gainesville, Florida open an account with Precision Biologics?+

Medspas operating under physician supervision can open an account once the supervising physician's NPI number is verified, with documentation provided before the first order.

What documentation does a dermatology practice need before adding a new biologics line?+

Request the lot certificate of analysis, donor eligibility summary, and a description of the recovery and release process for the specific product under review.

Does Florida's SB 1768 apply to aesthetic or medspa use of these products?+

SB 1768 concerns physician use of certain non-FDA-approved stem cell therapies under informed consent requirements; its scope and applicability should be confirmed with counsel and is not a basis for any marketing claim about these products.